SCHEMBL7988586

SCHEMBL7988586

Nc1cccc(-c2nc(=O)c3c(ncn3CCc3ccccc3)[nH]2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 6/20 0.50
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
RGS12 O14924 1/20 0.39
USP2 O75604 1/20 0.39
MAPT P10636 1/20 0.39
PARN O95453 1/20 0.39
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PRMT1 Q99873 1/20 0.39
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
MAPK1 P28482 1/20 0.38
PNP P00491 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7986359 0.94 CNOT7 (0.52) CNOT7ALDH1A1KDM4EMEN1KMT2A
SCHEMBL7984663 0.90 CNOT7 (0.49) CNOT7ALDH1A1KDM4EMEN1KMT2A
Hydrochloric Acid SCHEMBL7987663 0.89 CNOT7 (0.48) CNOT7ALDH1A1KDM4EMEN1KMT2A
SCHEMBL7974620 0.89 CNOT7 (0.58) CNOT7ALDH1A1KDM4EPARNLMNA
SCHEMBL7988553 0.88 CNOT7 (0.50) CNOT7ALDH1A1PARNPSMB2
SCHEMBL7984409 0.88 CNOT7 (0.53) CNOT7ALDH1A1KDM4EPARNLMNA
SCHEMBL7984686 0.88 CNOT7 (0.50) CNOT7ALDH1A1KDM4EPARNLMNA
SCHEMBL7989011 0.85 KDM4E (0.48) CNOT7ALDH1A1KDM4EMEN1KMT2A
SCHEMBL7988580 0.83 ALDH1A1 (0.44) CNOT7ALDH1A1KDM4EMEN1KMT2A
SCHEMBL7991681 0.83 CNOT7 (0.54) CNOT7ALDH1A1KDM4EMAPTPARN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed